Sources | Names Used |
---|---|
CTRPv2 | navitoclax:PLX-4032 (1:1 mol/mol) |
PharmacoGx | navitoclax:PLX-4032 (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PRKRA | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | EFNB3 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CEP162 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | ARFGEF3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | SCLT1 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
mRNA | ZNF219 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | CACHD1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | UBQLNL | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | C19orf47 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | BBS7 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |